Jason K Sa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Squamous Cell Carcinoma

Oxidative Stress

Top Venues

Journal for immunotherapy of cancer

Nature communications

Genome medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ju Won Kim, Kyungmin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong-Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for immunotherapy of cancer 12 (3) (2024)
Ju Won Kim, Kyungmin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong-Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for immunotherapy of cancer 12 (3) (2024)
Ju Won Kim, Kyungmin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong-Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for immunotherapy of cancer 12 (3) (2024)
Jung Yoon Choi, Kyong-Hwa Park, Yeul Hong Kim, Jason K Sa, Hwa Jung Sung, Yu-Wei Chen, Zhi-Shan Chen, Chao Li, Wanqing Wen, Qingrun Zhang, Christina E Bailey, Quan Long, Jung Sun Kim, Xingyi Guo
Large-Scale Cancer Genomic Analysis Reveals Significant Disparities Between Microsatellite Instability and Tumor Mutational Burden. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Byunghyun Jang, Dayoung Yoon, Ji Yoon Lee, Jiwon Kim, Jisoo Hong, Harim Koo, Jason K Sa
Integrative multi-omics characterization reveals sex differences in glioblastoma. Biology of sex differences 15 (1) (2024)
Ju Won Kim, Kyungmin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong-Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for immunotherapy of cancer 12 (3) (2024)
Jung Yoon Choi, Kyong-Hwa Park, Yeul Hong Kim, Jason K Sa, Hwa Jung Sung, Yu-Wei Chen, Zhi-Shan Chen, Chao Li, Wanqing Wen, Qingrun Zhang, Christina E Bailey, Quan Long, Jung Sun Kim, Xingyi Guo
Large-Scale Cancer Genomic Analysis Reveals Significant Disparities between Microsatellite Instability and Tumor Mutational Burden. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Ju Won Kim, Kyungmin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong-Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for immunotherapy of cancer 12 (3) (2024)
Ju Won Kim, Kyungmin Lee, Ji Yoon Lee, Sook Ryun Park, Yu Jung Kim, In Gyu Hwang, Woo Kyun Bae, Jae Ho Byun, Jung Sun Kim, Eun Joo Kang, Jeeyun Lee, Sang Joon Shin, Won Jin Chang, Eun-Ok Kim, Jason K Sa, Kyong-Hwa Park
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for immunotherapy of cancer 12 (3) (2024)
Byunghyun Jang, Dayoung Yoon, Ji Yoon Lee, Jiwon Kim, Jisoo Hong, Harim Koo, Jason K Sa
Integrative multi-omics characterization reveals sex differences in glioblastoma. Biology of sex differences 15 (1) (2024)
Quanhua Mu, Rui-Chao Chai, Bo Pang, Yingxi Yang, Hanjie Liu, Zheng Zhao, Zhaoshi Bao, Dong Song, Zhihan Zhu, Mengli Yan, Biaobin Jiang, Zongchao Mo, Jihong Tang, Jason K Sa, Hee Jin Cho, Yuzhou Chang, Kaitlin Hao Yi Chan, Danson Shek Chun Loi, Sindy Sing Ting Tam, Aden Ka Yin Chan, Angela Ruohao Wu, Zhaoqi Liu, Wai Sang Poon, Ho Keung Ng, Danny Tat-Ming Chan, Antonio Iavarone, Do-Hyun Nam, Tao Jiang, Ji-Guang Wang
Identifying predictors of glioma evolution from longitudinal sequencing. Science translational medicine 15 (716) (2023)
Jason K Sa, Jihye Kim, Sokbom Kang, Sang Wun Kim, Taejong Song, Seung-Hyuk Shim, Min Chul Choi, Jae Hong No, Jae-Yun Song, Deokhoon Kim, Yong-Man Kim, Jae-Hoon Kim, Jeong-Won Lee
Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047). International journal of cancer 151 (7) (2022)
Seung Tae Kim, Jason K Sa, Sung Yong Oh, Kyung Kim, Jung Yong Hong, Won Ki Kang, Kyoung-Mee Kim, Jeeyun Lee
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial. Genome medicine 13 (1) (2021)
Minsuk Kwon, Minae An, Samuel J Klempner, Hyuk Lee, Kyoung-Mee Kim, Jason K Sa, Hee Jin Cho, Jung Yong Hong, Yang Won Min, Tae Jun Kim, Woong-Yang Park, Won Ki Kang
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer. Cancer discovery 11 (9) (2021)
Kyong-Hwa Park, Jung Yoon Choi, Ah-Reum Lim, Ju Won Kim, Yoon Ji Choi, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Byunghyun Jang, Dayoung Yoon, Sukwon Kim, Jason K Sa, Yeul Hong Kim
Genomic landscape and clinical utility of Korean advanced pan-cancer patients from prospective clinical sequencing: K-MASTER program. Cancer discovery (2021)
E Sun Paik, Tae-Hyun Kim, Young Jae Cho, Jiyoon Ryu, Jung-Joo Choi, Yoo-Young Lee, Tae-Joong Kim, Chel-Hun Choi, Woo Young Kim, Jason K Sa, Jin-Ku Lee, Byoung-Gie Kim, Duk-Soo Bae, Hee Dong Han, Hyung Jun Ahn, Jeong-Won Lee
Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer. Scientific reports 10 (1) (2020)
Jinlong Yin, Sung Soo Kim, Eunji Choi, Young Taek Oh, Weiwei Lin, Tae-Hoon Kim, Jason K Sa, Jun Hee Hong, Se Hwan Park, Hyung Joon Kwon, Xiong Jin, Yeonhee You, Ji Hye Kim, Hyunggee Kim, Jaekyoung Son, Jeongwu Lee, Do-Hyun Nam, Kui Son Choi, Bingyang Shi, Ho-Shin Gwak, Heon Yoo, Antonio Iavarone, Jong Heon Kim, Jong Bae Park
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. Nature communications 11 (1) (2020)
Jason K Sa, Nakho Chang, Hye Won Lee, Hee Jin Cho, Michele Ceccarelli, Luigi Cerulo, Jinlong Yin, Sung Soo Kim, Francesca P Caruso, Mijeong Lee, Donggeon Kim, Young Taek Oh, Yeri Lee, Nam-Gu Her, Byeongkwi Min, Hye-Jin Kim, Da Eun Jeong, Hye-Mi Kim, Hyunho Kim, Seok Chung, Hyun Goo Woo, Jeongwu Lee, Doo-Sik Kong, Ho Jun Seol, Jung-Il Lee, Jinho Kim, Woong-Yang Park, Qianghu Wang, Erik P Sulman, Amy B Heimberger, Michael Lim, Jong Bae Park, Antonio Iavarone, Roel G W Verhaak, Do-Hyun Nam
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome biology 21 (1) (2020)
Sejin Oh, Jeonghun Yeom, Hee Jin Cho, Ju-Hwa Kim, Seon Jin Yoon, Hakhyun Kim, Jason K Sa, Shinyeong Ju, Hwanho Lee, Myung Joon Oh, Wonyeop Lee, Yumi Kwon, Honglan Li, Seunghyuk Choi, Jang Hee Han, Jong Hee Chang, Eunsuk Choi, Jayeon Kim, Nam-Gu Her, Se-Hoon Kim, Seok-Gu Kang, Eunok Paek, Do-Hyun Nam, Cheolju Lee, Hyun Seok Kim
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities. Nature communications 11 (1) (2020)
Jason K Sa, Jung Yong Hong, In-Kyoung Lee, Ju-Sun Kim, Moon-Hee Sim, Ha Jung Kim, Ji Yeong An, Tae Sung Sohn, Joon Ho Lee, Jae Moon Bae, Sung Kim, Kyoung-Mee Kim, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Nam-Gu Her, Yeri Lee, Hee Jin Cho, Yong Jae Shin, Misuk Kim, Harim Koo, Mirinae Kim, Yun Jee Seo, Ja Yeon Kim, Min-Gew Choi, Do-Hyun Nam, Jeeyun Lee
Comprehensive pharmacogenomic characterization of gastric cancer. Genome medicine 12 (1) (2020)
Barbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu, Paula Kroon, Ying Zhang, Marcos Galán-Ganga, Zhaoshi Bao, Zheng Wang, Hanjie Liu, Jason K Sa, Junfei Zhao, Hoon Kim, Sandra Rodriguez-Perales, Do-Hyun Nam, Roel G W Verhaak, Raúl Rabadán, Tao Jiang, Ji-Guang Wang, Massimo Squatrito
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nature communications 11 (1) (2020)
Hye Won Lee, Jason K Sa, Antonio Gualberto, Catherine Scholz, Hyun Hwan Sung, Byong Chang Jeong, Han Yong Choi, Ghee Young Kwon, Se Hoon Park
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Hee-Young Jeon, Seok Won Ham, Jun-Kyum Kim, Xiong Jin, Seon Yong Lee, Yong Jae Shin, Chang-Yong Choi, Jason K Sa, Se Hoon Kim, Taehoon Chun, Xun Jin, Do-Hyun Nam, Hyunggee Kim
Ly6G+ inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model. Cell death and differentiation 26 (10) (2019)
Jing Zhang, Francesca P Caruso, Jason K Sa, Sune Justesen, Do-Hyun Nam, Peter Sims, Michele Ceccarelli, Anna Lasorella, Antonio Iavarone
The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival. Communications biology 2 (2019)
Yong Jae Shin, Jason K Sa, Yeri Lee, Donggeon Kim, Nakho Chang, Hee Jin Cho, Miseol Son, Michael Y T Oh, Kayoung Shin, Jin-Ku Lee, Jiwon Park, Yoon Kyung Jo, Misuk Kim, Patrick J Paddison, Vinay Tergaonkar, Jeongwu Lee, Do-Hyun Nam
PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma. The Journal of experimental medicine 216 (5) (2019)
Jason K Sa, Seung Won Choi, Junfei Zhao, Yeri Lee, Jing Zhang, Doo-Sik Kong, Jung Won Choi, Ho Jun Seol, Jung-Il Lee, Antonio Iavarone, Raul Rabadan, Do-Hyun Nam
Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations. International journal of cancer 144 (12) (2019)